Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-16-000086

CEO bought 24,083 shares at an average $0.12 ($2,910)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-07-25 Purchase : show line 1 in the form +19,083 $0.11 $2,175 7,127,202 D
2016-07-25 Purchase : show line 2 in the form +5,000 $0.15 $735 7,132,202 D
Open-market purchases · 24,083 sh · avg $0.12 · $2,910
Loading xslF345X03/primary_doc.xml…